Código QR (código de barras bidimensional)

Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

Abstract Background Tremelimumab is an antibody that blocks CTLA-4 and demonstrates clinical efficacy in a subset of advanced melanoma patients. An unmet clinical need exists for blood-based response-predictive gene signatures to facilitate clinically effective and cost-efficient use of such immunot...

Fuld beskrivelse

Na minha lista:
Principais autores: Philip Friedlander, Karl Wassmann, Alan M. Christenfeld, David Fisher, Chrisann Kyi, John M. Kirkwood, Nina Bhardwaj, William K. Oh
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2017-08-01
Serier:Journal for ImmunoTherapy of Cancer
Fag:
Melanoma
Biomarker
Tremelimumab
CTLA-4
Predictive
Online adgang:http://link.springer.com/article/10.1186/s40425-017-0272-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker